Altria's Potential New Growth Driver

12/23/16

Altria's (NYSE:MO) international offspring, Philip Morris (NYSE:PM), recently submitted an application to the FDA seeking to attain Modified Risk Tobacco Product status for its iQOS electronic cigarette. Altria is set to cash in if the FDA approves the product since it has exclusive selling rights for it in the United States. The approval process will likely be a lengthy one and investors will be watching throughout 2017 for signs that this potential market disruptor will give Altria something it hasn't had for a while, a viable high growth segment.

Altria's traditional growth story is boring but consistent, relying on core brands to generate single digit earnings growth and copious amounts of cash flow. The company's iconic Marlboro brand accounts for the majority of operating income, which I calculate to be roughly 75%. This is derived from the company's reported category income mix and reported shipment volumes for cigarettes, where it specifically separates out the Marlboro brand.

READ FULL ARTICLE HERE